Result Summary for 110168
| Protocol ID: | 110168 |
| Clinical Study ID: | 110168 |
| Official Title: | Evaluation of the immunogenicity and safety of GlaxoSmithKline Biologicals' HPV vaccine 580299 when administered as a 3-dose schedule in healthy Japanese pre-adolescent and adolescent female subjects. |
| Phase: | phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | Human Papillomavirus Types 16 and 18 Vaccine |
| Trade/Product Name: | Cervarix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
